Moreover, immunohistochemical analysis of PM after treatment showed that combination therapy significantly increased the number of cleaved caspase-3-positive cells compared with monotherapy, indicating that combination therapy has better anti-tumor effects against PM. The gene discussed is CASP3; the disease is neoplasm.